← Ticker index
DVA
Ticker
DVA
Congressional Trades
12
by 3 members
Ticker disclosure brief
Congressional disclosure records for DVA
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Julie Johnson
SELL · 2025-09-25
Largest range
$1K – $15K
Julie Johnson
Longest observed gap
34d
Jerry Moran
Highest 30d vs SPY
67.3%
Julie Johnson
Purchase rows
3
25%
Sale rows
8
67%
Disclosed midpoint
$96K
range estimate
Unique Traders
3
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats8 · 67%
Republicans4 · 33%
Federal awards
all →- 2026-05-29$248KDepartment of Veterans AffairsACUTE INPATIENT DIALYSIS SERVICES
- 2026-05-29$0Department of Veterans AffairsINPATIENT DIALYSIS SERVICES
- 2026-05-13$3.8MDepartment of Veterans AffairsNATIONAL (VA-WIDE) DIALYSIS SERVICES EO 14398
- 2026-05-13$0Department of Veterans AffairsNATIONAL (VA-WIDE) DIALYSIS SERVICES EO 14398
- 2026-01-29$25.1MDepartment of Veterans AffairsEXPRESS REPORT: FY 26 DECEMBER NDSC EXPRESS REPORT
- 2026-01-26$632KDepartment of Veterans AffairsINPATIENT DIALYSIS SERVICES AT VACCHCS ORDERING PERIOD 2
Lobbying filings
all →- 2026-07-14$20KDAVITA INCHR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD) HR 2199/S 1173, the Restore Protections for Dialysis Patients Act CMS Kidney Care Choices model Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
- 2026-07-09$30KDAVITA INC.Issues related to the application of the Medicare Secondary Payer Act to dialysis services.
- 2026-07-06$50KDAVITADialysis services, FY2027 mil.con./ Veterans Affairs Appropriations Act, S.275, S.3466
- 2026-04-21$60KDAVITA INCIssues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173.
- 2026-04-20$1.2MDAVITA INCH.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Exclusion of skin substitute spend from PY 2025 CKCC Kidney Contracting Entities (KCE) benchmarks Issues related to billing for skin substitute products in value-based care models Issues related to hospice and concurrent dialysis H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Exclusion of skin substitute spend from PY 2025 CKCC Kidney Contracting Entitie
- 2026-04-20$70KDAVITA INC.H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Exclusion of skin substitute spend from PY 2025 Comprehensive Kidney Care Contracting (CKCC) Kidney Care Entities (KCE) benchmarks.
- 2026-04-20$60KDAVITA INC.Healthcare reimbursement policies; and issues relating to ESRD policies. Issues related to the budget and appropriations process. Issues relating to ESRD policies and reimbursement. Issues related to the Medicare Secondary Payer Act. S.1173: Restore Protections for Dialysis Patients Act H.R.2199 - Restore Protections for Dialysis Patients Act
- 2026-04-20$20KDAVITA INC.Building support among disability and minority organizations in support of H.R. 6860 and S.1173. companion.
- 2026-04-20$0DAVITA INC.
- 2026-04-17$90KDAVITA INC.Medicare and Medicaid reimbursement policies for specific kidney treatments.
Loading trade analytics…
All Disclosed Trades
Page 1 · 12 of 12 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2025-09-25 | DJulie Johnson | SELL | $1K – $15K | 13d | receipt → |
| 2025-09-25 | DJulie Johnson | SELL | $1K – $15K | 12d | receipt → |
| 2025-09-25 | DJulie Johnson | SELL | $1K – $15K | 12d | receipt → |
| 2025-09-25 | DJulie Johnson | SELL | $1K – $15K | 12d | receipt → |
| 2025-09-05 | DRo Khanna | SELL | $1K – $15K | 28d | receipt → |
| 2025-09-05 | DRo Khanna | SELL | $1K – $15K | 28d | receipt → |
| 2025-05-28 | DRo Khanna | BUY | $1K – $15K | 13d | receipt → |
| 2025-05-28 | DRo Khanna | BUY | $1K – $15K | 13d | receipt → |
| 2023-12-14 | RJerry Moran | SELL | $1K – $15K | 34d | receipt → |
| 2023-12-14 | RJerry Moran | SELL | $1K – $15K | 34d | receipt → |
| 2021-12-21 | RJerry Moran | PARTIAL_SELL | $1K – $15K | 615dApparent delay | receipt → |
| 2018-12-06 | RJerry Moran | BUY | $1K – $15K | 1726dApparent delay | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.